LDL-C
Live / Applied — Statement of use — registration review complete (as of 24 Mar 2026)
What this means for you
Not registered yet, but its 08 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98539735
- Mark type
- Design + words
- Filed
- 08 May 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 035 — Advertising and business services: promoting public awareness about treatments for metabolic diseases and disorders
- Class 044 — Medical, beauty and agricultural services: providing a website containing information about metabolic diseases and disorders
Owner
- Esperion Therapeutics, Inc., Ann Arbor, MI, US
- Esperion Therapeutics, Inc., Ann Arbor, MI, US
Prosecution history
- 24 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2025 — USE AMENDMENT FILED
- 20 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Sept 2025 — SOU EXTENSION 1 GRANTED
- 16 Sept 2025 — SOU EXTENSION 1 FILED
- 16 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER